QA: Savara Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001160308_2023_Savara_Inc.pdf

Logs

Graph

Absolute values for 0001160308, Savara Inc

  xvar xval
0 AssetsCurrent 128,954,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 51,000
3 remainder_Assets 10,772,000
4 LiabilitiesCurrent 5,867,000
5 LiabilitiesNoncurrent 26,132,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,939,215
9 ResearchAndDevelopmentExpense 27,916,316
10 remainder_Expenses 43,132
11 remainder_Revenues 0
12 remainder_NetIncome -234,173
13 remainder_ComprehensiveNetIncome -729,783
  yvar yval
0 Assets 139,777,000
1 Liabilities 31,999,000
2 Expenses 38,898,663
3 Revenues 0
4 StockholdersEquity 107,778,000
5 NetIncome -39,132,836
6 ComprehensiveNetIncome -39,497,728
7 BaseVar 105,819,310
8 EconomicCapitalRatiobeforeLimitedLiability 2.28
9 EconomicCapitalRatio 3.21

Edgar->Model Mapping

Feature Distribution

Change over Time